insights_auto
Utsikter: 67.3Â % optimistiske·1.9Â % pessimistiske
GÃ¥ til analysenchevron_right
EW:NYSE
Edwards Lifesciences Corp
104,25Â USD
arrow_upward
+0,23%(+0,24) 1Â D
11. nov., 10:04:04 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EW …
Ã…pne
103,76Â USD
Høy
104,59Â USD
Lav
102,73Â USD
Markedsverdi
59,82Â mrd.
Snittvolum
4,50Â mill.
Volum
193,60k
P/E-forhold
59,10
52 u høy
105,37Â USD
52Â u lav
74,66Â USD
EPS
1,76Â USD
Beta
0,85
Utestående aksjer
575,00Â mill.
Antall ansatte
16k
Ã…pne
103,76Â USD
Høy
104,59Â USD
Lav
102,73Â USD
Markedsverdi
59,82Â mrd.
Snittvolum
4,50Â mill.
Volum
193,60k
P/E-forhold
59,10
52 u høy
105,37Â USD
52Â u lav
74,66Â USD
EPS
1,76Â USD
Beta
0,85
Utestående aksjer
575,00Â mill.
Antall ansatte
16k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com Canada
·
for 4 timer siden
Form 144 Edwards Lifesciences Corp For: 11 November By Investing.com
Investing.com
·
for 7 timer siden
Edwards Lifesciences CVP sells $64,530 in shares
GuruFocus
·
for 14 timer siden
Edwards Lifesciences (EW) Insider Daniel Lippis Sells 619 Shares
Trefis
·
for 1 døgn siden
6 Green Days In A Row: Edwards Lifesciences Stock Is Up 14%
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Om Edwards Lifesciences Corp
Administrerende direktør-
Ansatte16k
Grunnlagt1958
HovedkontorIrvine, California, USA
SektorHealth Care
Bransje-
Nettstededwards.com